Maggie Renaud Young
About Maggie Renaud Young
Maggie Renaud Young is a Research and Development Project Manager and Clinical Lab Manager at CardiAI.Inc, with a strong academic background in Biochemistry and Molecular Biology. She has extensive experience in cancer research and biosensor technology, having co-founded FREDsense Technologies and contributed to significant projects in her field.
Current Role at CardiAI
Maggie Renaud Young serves as the Research and Development Project Manager and Clinical Lab Manager at CardiAI, Inc. since 2020. In this role, she oversees various projects related to research and development, focusing on advancing clinical laboratory practices. Her position involves managing teams and ensuring the successful execution of research initiatives within the organization.
Previous Experience at University of Calgary
Maggie Renaud Young worked at the University of Calgary as a Post-doctoral Fellow from 2015 to 2020. During her five years there, she contributed to research in the Biochemistry and Molecular Biology Department. Her work included a collaboration that led to the development of a point-of-contact sensor for Δ9-tetrahydrocannabinol.
Educational Background
Maggie Renaud Young earned her Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from the University of Calgary, where she studied from 2008 to 2015. Prior to that, she obtained a Master’s Degree in Developmental Biology and Cancer Biology from the University of Alberta from 1997 to 2001. She also holds a Bachelor of Science (B.Sc.) in Zoology/Animal Biology from the University of Alberta, completed from 1993 to 1997.
Co-founder Role at FREDsense Technologies
Since 2014, Maggie Renaud Young has been a co-founder of FREDsense Technologies. In this capacity, she has been involved in the development of innovative technologies, particularly focusing on biosensors. Her experience in research and development has contributed to the company's objectives and growth.
Research Specializations
Maggie Renaud Young specializes in designing and testing electrochemical drug and toxin biosensors. Her diverse research background includes investigating mechanisms of cancer development, showcasing her ability to learn and apply new methods to refine techniques in her field.